Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Glover

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Thyroid : Official Journal of the American Thyroid Association|June 15, 2022
Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral LymphadenopathyAlexander Papachristos, Kimchi Do, Venessa H Tsang, et al.
Endocrine Pathology|October 21, 2023
A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?John Turchini, Talia L Fuchs, Angela Chou, et al.
Endocrine Oncology (Bristol, England)|June 25, 2025
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centreMonica Majumder, Shejil Kumar, Tony Lian, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma"Nicholas Kesby, Robert Mechera, Talia Fuchs, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2023
Natural History and Predictive Factors of Outcome in Medullary Thyroid MicrocarcinomaNicholas Kesby, Robert Mechera, Talia Fuchs, et al.
BMJ Open|April 16, 2024
The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview studyBianka D'souza, Anthony Glover, Claire Bavor, et al.
European Thyroid Journal|September 20, 2021
Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre ExperienceAyanthi Wijewardene, Matti Gild, Carolina Nylén, et al.
Surgery|September 14, 2019
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancerJayani Jayasekara, Pascal Jonker, Jia Feng Lin, et al.
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines updateBenjamin J Worrall, Alexander Papachristos, Ahmad Aniss, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Thyroid : Official Journal of the American Thyroid Association|June 15, 2022
Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral LymphadenopathyAlexander Papachristos, Kimchi Do, Venessa H Tsang, et al.
Endocrine Pathology|October 21, 2023
A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?John Turchini, Talia L Fuchs, Angela Chou, et al.
Endocrine Oncology (Bristol, England)|June 25, 2025
Real-world lenvatinib use in metastatic thyroid cancer: early dose intensity and side effect profile in an Australian centreMonica Majumder, Shejil Kumar, Tony Lian, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Response to Letter to the Editor From Devgan and Mayilvaganan: "Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma"Nicholas Kesby, Robert Mechera, Talia Fuchs, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2023
Natural History and Predictive Factors of Outcome in Medullary Thyroid MicrocarcinomaNicholas Kesby, Robert Mechera, Talia Fuchs, et al.
BMJ Open|April 16, 2024
The impact of delayed diagnosis and treatment due to COVID-19 on Australian thyroid cancer patients: a qualitative interview studyBianka D'souza, Anthony Glover, Claire Bavor, et al.
European Thyroid Journal|September 20, 2021
Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre ExperienceAyanthi Wijewardene, Matti Gild, Carolina Nylén, et al.
Surgery|September 14, 2019
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancerJayani Jayasekara, Pascal Jonker, Jia Feng Lin, et al.
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines updateBenjamin J Worrall, Alexander Papachristos, Ahmad Aniss, et al.
Pageof 6